Canada-EU trade deal to affect pharma IP


A trade deal between the EU and Canada, due to be signed today (September 26) if last-minute German concerns can be overcome, would have implications for pharmaceutical IP protection and could raise the cost of drugs in Canada, a report has claimed.

pharmaceutical, patent protection, Canada, EU